Common Stocks - 98.9%
|
|||
Shares
|
Value ($)
|
||
UNITED STATES - 98.9%
|
|||
Health Care - 98.9%
|
|||
Health Care Providers & Services - 97.6%
|
|||
Acadia Healthcare Co Inc (a)
|
346,900
|
7,853,816
|
|
agilon health Inc (a)
|
4,902,760
|
10,884,127
|
|
Alignment Healthcare Inc (a)
|
955,933
|
14,692,690
|
|
Astrana Health Inc (a)(b)
|
235,300
|
5,833,087
|
|
BrightSpring Health Services Inc (a)(b)
|
1,136,700
|
27,064,827
|
|
Cencora Inc
|
160,600
|
46,773,144
|
|
Centene Corp (a)
|
817,484
|
46,138,797
|
|
Chemed Corp
|
56,500
|
32,478,460
|
|
Cigna Group/The
|
345,072
|
109,263,598
|
|
CVS Health Corp
|
1,759,670
|
112,689,267
|
|
Elevance Health Inc
|
74,602
|
28,635,232
|
|
Encompass Health Corp
|
343,900
|
41,577,510
|
|
HCA Healthcare Inc
|
65,300
|
24,904,767
|
|
Hinge Health Inc (a)
|
56,300
|
2,186,692
|
|
Humana Inc
|
56,500
|
13,171,845
|
|
LifeStance Health Group Inc (a)
|
3,353,059
|
19,917,170
|
|
McKesson Corp
|
108,000
|
77,707,080
|
|
Molina Healthcare Inc (a)
|
152,100
|
46,396,584
|
|
Option Care Health Inc (a)
|
774,100
|
25,297,588
|
|
Privia Health Group Inc (a)
|
1,061,764
|
24,165,749
|
|
Surgery Partners Inc (a)
|
1,218,436
|
28,767,274
|
|
Tenet Healthcare Corp (a)
|
182,800
|
30,851,156
|
|
UnitedHealth Group Inc
|
539,550
|
162,895,541
|
|
US Physical Therapy Inc (b)
|
163,300
|
12,245,867
|
|
952,391,868
|
|||
Health Care Technology - 1.3%
|
|||
Waystar Holding Corp (a)
|
325,200
|
13,001,496
|
|
TOTAL HEALTH CARE
|
965,393,364
|
||
TOTAL COMMON STOCKS
(Cost $618,643,716)
|
965,393,364
|
||
Convertible Preferred Stocks - 0.6%
|
|||
Shares
|
Value ($)
|
||
UNITED STATES - 0.6%
|
|||
Health Care - 0.6%
|
|||
Health Care Providers & Services - 0.0%
|
|||
Thriveworks Topco LLC Class B (a)(c)(d)(e)
|
69,639
|
285,520
|
|
Health Care Technology - 0.6%
|
|||
Aledade Inc Series B1 (a)(c)(e)
|
52,232
|
1,849,535
|
|
Aledade Inc Series E1 (a)(c)(e)
|
40,149
|
1,421,676
|
|
Aledade Inc Series F (a)(c)(e)
|
59,859
|
2,119,607
|
|
5,390,818
|
|||
TOTAL HEALTH CARE
|
5,676,338
|
||
TOTAL CONVERTIBLE PREFERRED STOCKS
(Cost $9,178,959)
|
5,676,338
|
||
Money Market Funds - 1.0%
|
||||
Yield (%)
|
Shares
|
Value ($)
|
||
Fidelity Cash Central Fund (f)
|
4.32
|
6,063,982
|
6,065,195
|
|
Fidelity Securities Lending Cash Central Fund (f)(g)
|
4.32
|
4,083,818
|
4,084,226
|
|
TOTAL MONEY MARKET FUNDS
(Cost $10,149,421)
|
10,149,421
|
|||
TOTAL INVESTMENT IN SECURITIES - 100.5%
(Cost $637,972,096)
|
981,219,123
|
NET OTHER ASSETS (LIABILITIES) - (0.5)%
|
(4,927,433)
|
NET ASSETS - 100.0%
|
976,291,690
|
(a)
|
Non-income producing
|
(b)
|
Security or a portion of the security is on loan at period end.
|
(c)
|
Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $5,676,338 or 0.6% of net assets.
|
(d)
|
Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.
|
(e)
|
Level 3 security
|
(f)
|
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
|
(g)
|
Investment made with cash collateral received from securities on loan.
|
Additional information on each restricted holding is as follows:
|
||
Security
|
Acquisition Date
|
Acquisition Cost ($)
|
Aledade Inc Series B1
|
5/07/21
|
2,000,000
|
Aledade Inc Series E1
|
5/20/22
|
1,999,998
|
Aledade Inc Series F
|
6/07/23
|
2,999,983
|
Thriveworks Topco LLC Class B
|
7/23/21 - 2/25/22
|
2,178,978
|
Affiliate
|
Value,
beginning
of period ($)
|
Purchases ($)
|
Sales
Proceeds ($)
|
Dividend
Income ($)
|
Realized
Gain (loss) ($)
|
Change in
Unrealized
appreciation
(depreciation) ($)
|
Value,
end
of period ($)
|
Shares,
end
of period
|
% ownership,
end
of period
|
Fidelity Cash Central Fund
|
1,773,554
|
41,955,255
|
37,663,614
|
46,269
|
-
|
-
|
6,065,195
|
6,063,982
|
0.0%
|
Fidelity Securities Lending Cash Central Fund
|
14,351,080
|
63,077,077
|
73,343,931
|
1,606
|
-
|
-
|
4,084,226
|
4,083,818
|
0.0%
|
Total
|
16,124,634
|
105,032,332
|
111,007,545
|
47,875
|
-
|
-
|
10,149,421
|
||